tiprankstipranks
Trending News
More News >
Saregama India Limited (IN:SAREGAMA)
:SAREGAMA
India Market

Saregama India Limited (SAREGAMA) AI Stock Analysis

Compare
1 Followers

Top Page

IN:SAREGAMA

Saregama India Limited

(SAREGAMA)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
₹349.00
▼(-2.42% Downside)
Action:ReiteratedDate:02/06/26
The score is supported by a strong, low-leverage balance sheet and solid profitability, but is pulled down by the sharp TTM revenue decline and weakened cash conversion/FCF. Technically, the stock remains in a downtrend (below major DMAs with negative MACD), while valuation looks somewhat expensive despite a moderate dividend yield.
Positive Factors
Conservative balance sheet
Very low leverage and a solid equity base provide durable financial flexibility. This supports investment in new content, enables opportunistic M&A or catalogue purchases, and helps the company weather cyclical revenue shocks without forcing asset sales or aggressive cost cuts.
Healthy profitability and margins
Saregama’s multi-year track record of healthy gross and net margins indicates pricing power and cost control in core licensing and distribution. Sustainable margins support reinvestment in content, dividend payouts, and funding of production initiatives despite periodic revenue swings.
Diversified content monetization model
A business model that earns from licensing, streaming royalties, content production, and direct-to-consumer offerings creates multiple, partly recurring revenue streams. This diversification reduces single-channel dependency and supports long-term cash generation as consumption shifts.
Negative Factors
Significant TTM revenue decline
A near‑term ~19% drop in trailing revenues is structurally meaningful: it can erode catalogue monetization momentum and reduce bargaining leverage with platforms and licensees. Prolonged revenue contraction would limit content investment and weaken long‑term growth prospects.
Weak cash conversion / zero FCF
Material deterioration in cash conversion and zero free cash flow in the TTM hampers the company’s ability to self‑fund content acquisition, production, and dividends. Persistent weak OCF relative to earnings reduces financial resilience and raises funding risk for strategic initiatives.
Dependence on platform terms and consumption volumes
Revenue and royalties are structurally tied to third‑party streaming and platform contracts. Changes in platform payout policies, algorithmic distribution, or user engagement trends can durably compress revenues and margins, limiting predictability of long‑term cash flows.

Saregama India Limited (SAREGAMA) vs. iShares MSCI India ETF (INDA)

Saregama India Limited Business Overview & Revenue Model

Company DescriptionSaregama India Limited engages in the sound recording and publishing business in India and internationally. The company operates through Music, Films/TV Serials, and Publication segments. The Music segment manufactures and sells music storage devices, such as carvaan, mini carvaan, music cards, audio compact discs, digital versatile discs, etc., as well as deals with related music rights. The Films/TV Serials segment produces, sells, telecasts, and broadcasts films, TV serials, and pre-recorded programs, as well as deals in film rights. The Publication segment publishes OPEN, a weekly current affairs magazine. The company was formerly known as Gramophone Company of India Ltd. The company was founded in 1901 and is headquartered in Mumbai, India. Saregama India Limited is a subsidiary of Composure Services Private Limited.
How the Company Makes MoneySaregama generates revenue through multiple streams, primarily from music licensing, digital streaming, and product sales. The company earns significant income from licensing its extensive music catalog to films, television shows, and advertisements. Additionally, SAREGAMA has a growing presence in the digital space, partnering with streaming platforms to provide its content, which contributes to its revenue through digital royalties. The sales of the Saregama Carvaan and other music-related products also form an essential revenue stream. Strategic partnerships with various digital platforms and collaborations with artists further enhance its earnings potential.

Saregama India Limited Financial Statement Overview

Summary
Balance sheet strength is a major positive (very low leverage; healthy ROE), but the latest TTM shows a ~19% revenue decline and materially weaker cash conversion (OCF to net income ~0.09; free cash flow at zero), which weighs on near-term performance quality.
Income Statement
71
Positive
Profitability remains a clear strength, with healthy TTM (Trailing-Twelve-Months) margins (gross profit ~44%, net margin ~20%). However, the latest TTM (Trailing-Twelve-Months) revenue is down ~19% versus the prior period, and margins are also lower than the strong FY2024 levels, pointing to a weaker near-term growth and profitability trajectory despite a generally solid multi-year track record.
Balance Sheet
90
Very Positive
The balance sheet is conservatively positioned with very low leverage (TTM debt-to-equity ~0.05; near-zero in recent annual periods) and a solid equity base. Returns on equity are consistently healthy (roughly ~12–14% in recent years), supporting strong financial flexibility; the main watch item is the recent uptick in debt in the TTM (Trailing-Twelve-Months), albeit still modest.
Cash Flow
44
Neutral
Cash generation has been volatile. In the latest TTM (Trailing-Twelve-Months), operating cash flow is low relative to earnings (operating cash flow to net income ~0.09) and free cash flow is reported at zero, which is a meaningful deterioration versus FY2025 (free cash flow positive and ~51% of net income). Prior years also show swings, including negative free cash flow in FY2023, indicating less consistent cash conversion.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue9.38B11.71B8.03B7.37B5.76B4.33B
Gross Profit4.13B4.52B4.73B4.13B3.57B2.64B
EBITDA3.06B2.77B3.10B2.70B2.30B1.58B
Net Income1.92B2.04B1.98B1.85B1.53B1.13B
Balance Sheet
Total Assets22.86B20.95B20.34B17.04B16.88B7.84B
Cash, Cash Equivalents and Short-Term Investments5.54B1.81B1.74B2.55B6.83B1.33B
Total Debt799.00M27.00M54.33M7.13M13.03M11.02M
Total Liabilities6.65B5.08B5.61B3.59B3.07B2.75B
Stockholders Equity16.17B15.83B14.69B13.42B13.78B5.06B
Cash Flow
Free Cash Flow0.001.70B9.71M-183.60M217.12M1.68B
Operating Cash Flow528.30M3.31B932.45M848.20M944.25M1.90B
Investing Cash Flow-612.10M-2.21B165.94M-1.41B-6.30B-1.36B
Financing Cash Flow-1.24B-987.30M-848.64M-756.00M6.77B-494.80M

Saregama India Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price357.65
Price Trends
50DMA
340.33
Positive
100DMA
362.84
Negative
200DMA
424.83
Negative
Market Momentum
MACD
1.74
Negative
RSI
52.51
Neutral
STOCH
56.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SAREGAMA, the sentiment is Neutral. The current price of 357.65 is above the 20-day moving average (MA) of 335.90, above the 50-day MA of 340.33, and below the 200-day MA of 424.83, indicating a neutral trend. The MACD of 1.74 indicates Negative momentum. The RSI at 52.51 is Neutral, neither overbought nor oversold. The STOCH value of 56.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:SAREGAMA.

Saregama India Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
₹69.96B13.882.65%-4.67%43.27%
59
Neutral
₹66.45B32.872.59%26.97%8.03%
55
Neutral
₹10.21B-12.87-50.42%2921.37%
45
Neutral
₹2.63B-1.32-2.93%-50.62%
43
Neutral
₹154.90M-4.58-79.97%-219.35%
37
Underperform
₹756.76M-69.51%71.68%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SAREGAMA
Saregama India Limited
344.80
-164.23
-32.26%
IN:BALAJITELE
Balaji Telefilms Limited
83.85
26.96
47.39%
IN:EROSMEDIA
Eros International Media Limited
7.89
0.07
0.90%
IN:RADAAN
Radaan Mediaworks (I) Ltd.
2.86
-1.21
-29.73%
IN:SHEMAROO
Shemaroo Entertainment Ltd.
96.20
-15.05
-13.53%
IN:ZEEL
Zee Entertainment Enterprises Limited
72.84
-30.33
-29.40%

Saregama India Limited Corporate Events

Saregama Closes Trading Window Ahead of Q3 FY26 Results
Dec 26, 2025

Saregama India Limited has announced the closure of its trading window for designated persons and their immediate relatives from 1 January 2026 until 48 hours after the company announces its unaudited financial results for the third quarter and nine months ended 31 December 2025. The move, taken under SEBI’s Prohibition of Insider Trading Regulations and the company’s own insider trading code, is a standard governance measure aimed at preventing insider trading ahead of earnings disclosure, signalling continued regulatory compliance and safeguarding fair market practices for investors.

Saregama Independent Director Santanu Bhattacharya Completes Final Board Term
Dec 21, 2025

Saregama India Limited has announced that independent director Santanu Bhattacharya has completed his second and final term on the board and ceased to be an independent director with effect from the close of business on 21 December 2025. The board has formally recorded its appreciation for Bhattacharya’s contributions, and the company has updated its official list of directors and key managerial personnel, signaling a routine governance transition in line with SEBI’s listing and disclosure regulations.

Saregama India Limited Releases Unaudited Financial Results for Q2 2025
Nov 6, 2025

Saregama India Limited has announced the approval of its unaudited financial results for the quarter and half-year ending on September 30, 2025. The results, which have been published in major newspapers, reflect the company’s financial performance and are accessible on both the stock exchanges and the company’s website. This announcement underscores Saregama’s commitment to transparency and provides stakeholders with important insights into its financial health.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 06, 2026